Heterocyclic N-oxides-an emerging class of therapeutic agents

AM Mfuh, OV Larionov - Current medicinal chemistry, 2015 - ingentaconnect.com
Heterocyclic N-oxides have emerged as potent compounds with anticancer, antibacterial,
antihypertensive, antiparasitic, anti-HIV, anti-inflammatory, herbicidal, neuroprotective, and …

Role of the active-site solvent in the thermodynamics of factor Xa ligand binding

R Abel, T Young, R Farid, BJ Berne… - Journal of the American …, 2008 - ACS Publications
Understanding the underlying physics of the binding of small-molecule ligands to protein
active sites is a key objective of computational chemistry and biology. It is widely believed …

Classification of water molecules in protein binding sites

C Barillari, J Taylor, R Viner… - Journal of the American …, 2007 - ACS Publications
Water molecules play a crucial role in mediating the interaction between a ligand and a
macromolecular receptor. An understanding of the nature and role of each water molecule in …

Discovery of TMPRSS2 inhibitors from virtual screening as a potential treatment of COVID-19

X Hu, JH Shrimp, H Guo, M Xu, CZ Chen… - ACS pharmacology & …, 2021 - ACS Publications
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
prompted researchers to pivot their efforts to finding antiviral compounds and vaccines. In …

Thermodynamics of water in an enzyme active site: grid-based hydration analysis of coagulation factor Xa

CN Nguyen, A Cruz, MK Gilson… - Journal of chemical …, 2014 - ACS Publications
Water molecules in the active site of an enzyme occupy a complex, heterogeneous
environment, and the thermodynamic properties of active-site water are functions of position …

Torsion angle preferences in druglike chemical space: a comprehensive guide

C Scharfer, T Schulz-Gasch, HC Ehrlich… - Journal of Medicinal …, 2013 - ACS Publications
Crystal structure databases offer ample opportunities to derive small molecule conformation
preferences, but the derived knowledge is not systematically applied in drug discovery …

The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development

KR Guertin, YM Choi - Current medicinal chemistry, 2007 - ingentaconnect.com
Factor Xa (fXa) is a critical serine protease situated at the confluence of the intrinsic and
extrinsic pathways of the blood coagulation cascade. FXa catalyses the conversion of …

Effective estimation of ligand-binding affinity using biased sampling method

ST Ngo, KB Vu, LM Bui, VV Vu - ACS omega, 2019 - ACS Publications
The binding between two biomolecules is one of the most critical factors controlling many
bioprocesses. Therefore, it is of great interest to derive a reliable method to calculate the free …

Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials

A Evers, H Gohlke, G Klebe - Journal of molecular biology, 2003 - Elsevier
A new approach, MOBILE, is presented that models protein binding-sites including bound
ligand molecules as restraints. Initially generated, homology models of the target protein are …

Cation–π interactions at the active site of factor Xa: dramatic enhancement upon stepwise N‐alkylation of ammonium ions

LM Salonen, C Bucher, DW Banner… - Angewandte Chemie …, 2009 - Wiley Online Library
Efficient ligands of factor Xa usually feature a more or less preorganized central scaffold
which orients two approximately orthogonal vectors to fill the S1 and S4 pockets at the …